Kane Biotech in sales representation pact with SLA Brands

V6U8nBkP.jpg

Kane Biotech (TSXV:KNE) entered a strategic partnership with Schiaffino, Lasky, & Associates (SLA Brands) to exclusively represent Kane’s bluestem line of products to distributors and retailers in the U.S. market.

“We are extremely pleased to be working with such a well-respected group within the pet industry and look forward to expanding the retail footprint of our bluestem line of products across the U.S. market,” Marc Edwards, Kane’s CEO, said in a statement.

“We’ve seen tremendous growth in this line of products over the past few months and expect SLA’s representation in a key market to further accelerate our market expansion,” he added.

Bill Schiaffino, founder and president of SLA Brands, said that as one of the most comprehensive pet oral care lines on the market, “we anticipate strong sales of Kane’s bluestem products.”

Michelle Carr